Correlation found between pulmonary small vessels alteration, pulmonary perfusion

Pulmonary small vessels alteration is significantly correlated with pulmonary perfusion, according to a study published in the April issue of the American Journal of Roentgenology.

Pulmonary vascular alterations are vital to the understanding of pathophysiologic manifestations of lung disorders. To quantitatively evaluate these alterations in vivo, many are suggesting the use of cross-sectional area (CSA) measurements of pulmonary small vessels. Lead author Shin Matsuoka, MD, PhD, of the St. Marianna University School of Medicine in Kanagawa, Japan, and colleagues examined the relationship between the pulmonary small vessels alteration, as measured by CSA on CT images, and pulmonary perfusion measured using lung perfusion scintigraphy.

The researchers’ study included 46 patients who underwent CT and lung perfusion scintigraphy. The CSA of pulmonary small vessels less than five millimeters2 and between five and ten millimeters2 were measured using CT. The percentage of the right lung to whole lung in each CSA group, measured as CSA<5,R/W and CSA5–10,R/W, were ascertained.

Additionally, Matsuoka and colleagues used 99mTc–macroaggregated albumin (MAA) lung perfusion scintigraphy to gather the right and total lung counts, and calculated the percentage of the right-to-whole lung counts, known as MAAR/W. They also evaluated the correlations of CSA<5,R/W and CSA5–10,R/W with MAAR/W, the correlation between the percentage of each lung zone to whole-lung CSA<5 and the percentage of each corresponding lung zone to whole-lung MAA.

Results indicated that the mean CSA<5,R/W was 58.1 percent and the mean MAAR/W was 59.3 percent. While CSA<5,R/W was significantly correlated with MAAR/W, a significant but weak correlation was found between CSA5–10,R/W and MAAR/W. Lastly, the percentage of each lung zone to whole-lung CSA<5 had significant correlations with the percentage of each corresponding lung zone to whole-lung MAA.

“Data from the current study suggest that reduction in CSA of subsubsegmental vessels might be related to a decrease in pulmonary perfusion,” wrote Matsuoka and colleagues. “This is a first report to establish a relationship between quantitative measurements of pulmonary small vessels alteration and pulmonary perfusion in vivo. CSA measurements may represent an alternative imaging technique for the evaluation of pulmonary perfusion.”

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.